cellulite/obesity

FIELD OF THE INVENTION The present invention relates to using rhamnolipids for treating obesity and obesity-related conditions such as metabolic syndrome, hypertension, type 2 diabetes, non-alcoholic fatty liver disease or obesity-related kidney disease. BACKGROUND OF THE INVENTION Obesity is a

FIELD OF THE INVENTION The present invention relates to using rhamnolipids for treating obesity and obesity-related conditions such as metabolic syndrome, hypertension, type 2 diabetes, non-alcoholic fatty liver disease or obesity-related kidney disease. BACKGROUND OF THE INVENTION Obesity is a

TECHNICAL FIELD The present invention relates to a lipolysis stimulator and a slimming agent which are effective for inhibition or prevention of obesity, amelioration of prone to obesity and the like. BACKGROUND OF THE INVENTION Life styles in developed countries induce lack of physical exercise and

The present invention relates to the field of medical approaches for diseases in which lipid accumulation takes place in one or several animal tissues and organs, such as overweight, obesity, hepatic steatosis or some cardiovascular diseases. The invention also applies to cosmetic methods for

The invention concerns Allium sativum (garlic) bulb extracts and uses thereof. Said compositions can be advantageously and more particularly used in the pharmaceutical and cosmetics industry. The invention thus also concerns therapeutic compositions (medicaments), particularly for the treatment of

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention in general relates to natural fat modulators. More specifically, the present invention relates to novel, bioavailable and safe stilbenoid 3,5-dimethoxy-3,4'-dihydroxystilbene possessing an unexpected enhanced ability to

FIELD OF THE INVENTION The present invention relates to using rhamnolipids for treating obesity and obesity-related conditions such as metabolic syndrome, hypertension, type 2 diabetes, non-alcoholic fatty liver disease or obesity-related kidney disease. BACKGROUND OF THE INVENTION Obesity is a

The invention relates to an antiadipose topical treatment composition and to the uses of this composition and/or of garlic bulbs extracts cosmetically for preventively or curatively treating cellulite and localized dermal excess adipose, or therapeutically for treating obesity. More than 90% of